Juno Therapeutics CEO Bishop set for $200M+ payday with Celgene buyout
admin 22nd January 2018 Uncategorised 0Juno Therapeutics CEO Hans Bishop is in line for a nice payday when his company seals the deal with Celgene. Think $200 million or more. More: Juno Therapeutics CEO Bishop set for 0M+ payday with Celgene buyout Source: fierce
read more